Overview
- Rocket Lab reported a surge in commercial bookings, selling a record 31 launch contracts in its recent quarter and building a backlog near $2.2 billion that more than doubled year over year.
- Two large U.S. Space Force awards — a $397 million contract to develop, launch and operate advanced flat satellites and a separate $266 million deal covering 12 suborbital launches plus options — significantly expand near-term, multi‑year work tied to the Neutron program.
- The company remains unprofitable: adjusted EBITDA loss narrowed to $11.8 million and the quarter showed a roughly $45 million net loss, results that beat some estimates but leave profitability questions unresolved.
- Despite analyst upgrades and an average price target near $111 that implies notable upside, the stock sits far below its recent peak after a steep decline, leaving valuation and investor confidence at odds with operational momentum.
- Rocket Lab enters a phase where converting the contracted backlog into finished Neutron launches and recurring government revenue will determine cash flow and the company’s ability to justify its high price‑to‑sales multiple and current market value.